Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/25/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/05/25
End: 02/27/29
Due: 02/27/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours | NCT06597721 | Adcendo ApS | user2@example.com | None | 2024-11-25 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma | NCT06797999 | Adcendo ApS | user2@example.com | None | 2025-06-05 | 2029-02-27 | 2030-02-27 | - | - | 2025-07-14 |